首页> 中文期刊> 《介入放射学杂志》 >明胶海绵微粒联合TACE治疗原发性肝癌的护理

明胶海绵微粒联合TACE治疗原发性肝癌的护理

         

摘要

目的 探讨新型明胶海绵微粒联合TACE治疗原发性肝癌的护理方法.方法 2009年6月-2011年5月,针对应用明胶海绵微粒行TACE术治疗原发性肝癌患者的99例患者行围手术期护理干预,重点包括术前心理护理、介入术中护理及术后并发症护理,观察和总结此方法治疗原发性肝癌的护理特点.结果 护理干预99例患者,其中包括巨块型肝癌70例,结节型肝癌22例,1例患者术后出现肝脓肿,5例患者出现急性胆囊炎,6个月生存率为90.9%,12个月生存率为82.82%.结论 明胶海绵微粒化疗栓塞原发性肝癌疗效肯定,应用循证护理正确认识和总结该新方法的护理特点对患者的预后尤为重要.%Objective To investigate the nursing measures for patients with primary hepatocellular carcinoma who receive TACE combined with gelatin sponge particles (350 - 560 μm). Methods During the period from June 2009 to May 2011, a total of 99 patients with primary hepatocellular carcinoma who received TACE combined with gelatin sponge particles were admitted to authors' hospital. Perioperative nursing intervention measures were carried out, including preoperative psychological nursing, special nursing during operation and postoperative nursing for complications. The nursing characteristics were summarized. Results Nursing intervention was conducted in 99 patients. The diseases included liver cancer of massive type (n = 70), liver cancer of nodular type (n = 22). After the treatment, liver abscess occurred in one patient and acute cholecystitis in five patients. The total 6-month and 12-month survival rates were 90.90% and 82.82% , respectively. Conclusion Interventional chemoembolization with gelatin sponge particles has reliable effect for primary hepatocellular carcinoma. With the help of evidence - based nursing measures, correct understanding, proper summary and active use of these new nursing measures are very important for patient's prognosis.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号